Literature DB >> 10593821

Should a cytologic study be ordered in transudative pleural effusions?

J M Porcel, M Alvarez, A Salud, M Vives.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10593821     DOI： 10.1378/chest.116.6.1836

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  5 in total

1.  Predictive models of malignant transudative pleural effusions.

Authors:  Lucía Ferreiro; Francisco Gude; María E Toubes; Adriana Lama; Juan Suárez-Antelo; Esther San-José; Francisco Javier González-Barcala; Antonio Golpe; José M Álvarez-Dobaño; Carlos Rábade; Nuria Rodríguez-Núñez; Carla Díaz-Louzao; Luis Valdés
Journal:  J Thorac Dis       Date:  2017-01       Impact factor: 2.895

Review 2.  The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusion.

Authors:  Michael Bradshaw; Aaron Mansfield; Tobias Peikert
Journal:  Curr Oncol Rep       Date:  2013-06       Impact factor: 5.075

3.  An unusual transudative pleural effusion succeeded by pulmonary and brain edema and death.

Authors:  Sayyed Gholam Reza Mortazavimoghaddam; H R Riasi
Journal:  Case Rep Pulmonol       Date:  2012-03-28

Review 4.  Diagnostics in Pleural Disease.

Authors:  Anand Sundaralingam; Eihab O Bedawi; Najib M Rahman
Journal:  Diagnostics (Basel)       Date:  2020-12-04

5.  What is the clinical significance of transudative malignant pleural effusion?

Authors:  Jeong-Seon Ryu; Seong-Tae Ryu; Young-Shin Kim; Jae-Hwa Cho; Hong-Lyeol Lee
Journal:  Korean J Intern Med       Date:  2003-12       Impact factor: 2.884
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.